Soria J - Search Results

1

Effects of Abciximab on the architecture of platelet-rich clots in patients with acute myocardial infarction undergoing primary coronary intervention.

Collet JP, Montalescot G, Lesty C, Mishal Z, Soria J, Choussat R, Drobinski G, Soria C, Pinton P, Barragan P, Thomas D. Collet JP, et al. Among authors: soria j, soria c. Circulation. 2001 May 15;103(19):2328-31. doi: 10.1161/01.cir.103.19.2328. Circulation. 2001. PMID: 11352878 Clinical Trial.

2

Pharmacological remodeling of the thrombus architecture.

Collet JP, Montalescot G, Soria J, Mishal Z, Soria C. Collet JP, et al. Among authors: soria j, soria c. Blood Coagul Fibrinolysis. 1999 Feb;10 Suppl 1:S49-53. Blood Coagul Fibrinolysis. 1999. PMID: 10070819 Review. No abstract available.

3

Disaggregation of in vitro preformed platelet-rich clots by abciximab increases fibrin exposure and promotes fibrinolysis.

Collet JP, Montalescot G, Lesty C, Soria J, Mishal Z, Thomas D, Soria C. Collet JP, et al. Among authors: soria j, soria c. Arterioscler Thromb Vasc Biol. 2001 Jan;21(1):142-8. doi: 10.1161/01.atv.21.1.142. Arterioscler Thromb Vasc Biol. 2001. PMID: 11145946

4

Influence of fibrin network conformation and fibrin fiber diameter on fibrinolysis speed: dynamic and structural approaches by confocal microscopy.

Collet JP, Park D, Lesty C, Soria J, Soria C, Montalescot G, Weisel JW. Collet JP, et al. Among authors: soria j, soria c. Arterioscler Thromb Vasc Biol. 2000 May;20(5):1354-61. doi: 10.1161/01.atv.20.5.1354. Arterioscler Thromb Vasc Biol. 2000. PMID: 10807754

5

Effect of heparin and enoxaparin on platelet interaction with fibrin clots.

Mirshahi M, Soria J, Neuhart E, Steg PG, Jacob P, Combe S, Soria C. Mirshahi M, et al. Among authors: soria j, soria c. Thromb Res. 1992 Jan 15;65(2):187-91. doi: 10.1016/0049-3848(92)90238-6. Thromb Res. 1992. PMID: 1315989

6

[Fibrinogen, a vascular risk factor].

Caen JP, Soria J, Collet JP, Soria C. Caen JP, et al. Among authors: soria j, soria c. Bull Acad Natl Med. 1993 Nov;177(8):1433-41; discussion 1441-4. Bull Acad Natl Med. 1993. PMID: 8193948 French.

7

[The biology of fibrinogen. The role of pentoxifylline].

Soria J, Soria C. Soria J, et al. Among authors: soria c. J Mal Vasc. 1989;14 Suppl A:25-8. J Mal Vasc. 1989. PMID: 2654312 Review. French.

8

Abnormal fibrin clot architecture in nephrotic patients is related to hypofibrinolysis: influence of plasma biochemical modifications: a possible mechanism for the high thrombotic tendency?

Colle JP, Mishal Z, Lesty C, Mirshahi M, Peyne J, Baumelou A, Bensman A, Soria J, Soria C. Colle JP, et al. Among authors: soria j, soria c. Thromb Haemost. 1999 Nov;82(5):1482-9. Thromb Haemost. 1999. PMID: 10595642

9

Hemostasis in patients undergoing extracorporeal circulation: the effect of aprotinin (Trasylol).

Lu H, Soria C, Commin PL, Soria J, Piwnica A, Schumann F, Regnier O, Legrand Y, Caen JP. Lu H, et al. Among authors: soria j, soria c. Thromb Haemost. 1991 Dec 2;66(6):633-7. Thromb Haemost. 1991. PMID: 1724577 Clinical Trial.

10

Dysfibrinogenemia and thrombosis.

Soria J, Soria C, Collet JP, Mirishahi M, Lu H, Caen JP. Soria J, et al. Among authors: soria c. Nouv Rev Fr Hematol (1978). 1991;33(6):457-9. Nouv Rev Fr Hematol (1978). 1991. PMID: 1818298

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

1,378 results

Search Page

Filters